Godavari Biorefineries Limited — Investor Meet, 18-02-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Godavari Biorefineries posted Q3 FY26 consolidated total income of Rs. 461.9 Cr (+2.5% YoY) and EBITDA of Rs. 45.1 Cr (9.8% margin), with PBT surging 152% to Rs. 21.4 Cr, aided by reduced finance costs. For 9M FY26, total income hit Rs. 1,430.2 Cr (+10.2% YoY). Bio-based chemicals saw Q3 revenue rise 3.8% to Rs. 142.3 Cr and EBITDA jump 76.7% to Rs. 10.9 Cr, driven by specialty chemicals. Ethanol revenue dipped in Q3 but showed strong 9M growth (+29.5%) due to B-heavy molasses availability. The company progresses on its CO2-to-DME pilot and cancer drug development, with its Jivana consumer brand achieving Rs. 100 Cr revenue in 9M FY26.